MergerLinks - Request Credit - Fidelity Management & Research Company and OrbiMed led a $81m Series B round in Evozyne.

Submit Deal

Request Deal Involvement

Fidelity Management & Research Company and OrbiMed led a $81m Series B round in Evozyne.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Principals

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.

To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal: